CHROnic Migraine Embolization
NCT: NCT06848166 · ENROLLING_BY_INVITATION
Brief Summary
To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUID 12 and SQUID 18 as a treatment method for patients with chronic resistant migraine.
Frequently Asked Questions
What is CHROnic Migraine Embolization?
CHROnic Migraine Embolization is a clinical trial registered under NCT06848166. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT06848166?
The current status of NCT06848166 (CHROnic Migraine Embolization) is: ENROLLING_BY_INVITATION.
When did CHROnic Migraine Embolization start?
CHROnic Migraine Embolization started on 2024-10-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.